应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AMAM Ambrx Biopharma Inc
停牌 08-23 16:00:00 EDT
28.00
+0.00
0.00%
最高
28.00
最低
28.00
成交量
0.00
今开
28.00
昨收
28.00
日振幅
0.00%
总市值
17.74亿
流通市值
5.86亿
总股本
6,335万
成交额
0.00
换手率
0.00%
流通股本
2,093万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
BUZZ-预览:强生股价在季度业绩公布前上涨
Reuters · 04-16
BUZZ-预览:强生股价在季度业绩公布前上涨
公司概况
公司名称:
Ambrx Biopharma Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
Ambrx Biopharma, Inc.是一家根据特拉华州法律成立的公司。该公司是一家临床阶段的生物制剂公司,专注于发现和开发一类新的工程精密生物制剂(EPBs),利用其专有的扩展遗传密码技术平台,使他们能够以特定地点的方式将合成氨基酸(SAA)整合到活细胞内的蛋白质中。它们的候选产品旨在克服传统结合方法的固有局限性,这些方法使用天然氨基酸进行非位点特异性结合,为治疗多个治疗领域的患者提供潜在的安全性和有效性益处。
发行价格:
--
{"stockData":{"symbol":"AMAM","market":"US","secType":"STK","nameCN":"Ambrx Biopharma Inc","latestPrice":28,"timestamp":1724443200000,"preClose":28,"halted":3,"volume":0,"delay":0,"floatShares":20929300,"shares":63352171,"eps":-0.237682,"marketStatus":"停牌","marketStatusCode":7,"change":0,"latestTime":"08-23 16:00:00 EDT","open":28,"high":28,"low":28,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.237682,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"listingDate":1623988800000,"adjPreClose":28,"adrRate":7,"volumeRatio":0},"requestUrl":"/m/hq/s/AMAM/wiki","defaultTab":"wiki","newsList":[{"id":"2427988642","title":"BUZZ-预览:强生股价在季度业绩公布前上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2427988642","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2427988642?lang=zh_cn&edition=full","pubTime":"2024-04-16 00:53","pubTimestamp":1713200014,"startTime":"0","endTime":"0","summary":" 4月15日 - ** 强生 股价周一上涨0.6%至148.38美元,该公司将在周二开盘前公布季度财报。** 在过去的 8 个季度中,JNJ 的每股收益每次都达到或超过华尔街的预期,而每股收益则 6 次超过分析师的预期。** 根据 Trade Alert 的数据,JNJ 期权意味着该股在周五之前会有 2.6% 的双向波动;这高于该股在过去 8 个季度业绩公布当天 2.0% 的平均波动率。** 与标普 500 医疗保健指数 的 2.3% 涨幅和道琼斯工业平均指数 的 0.8% 涨幅相比,JNJ 的年累计跌幅约为 5%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930813.SGD","LU1032466523.USD","LU0795875086.SGD","LU0792757196.USD","IE00B19Z3581.USD","SG9999002232.USD","LU1732800096.USD","LU1066053197.SGD","LU0466842654.USD","LU0053671581.USD","LU1261432733.SGD","SG9999001440.SGD","BK4539","BK4581","IE00BSNM7G36.USD","AMAM","SWAV","LU1244550577.SGD","LU1059921491.USD","BK4532","LU0912757837.SGD","IE0002270589.USD","LU1196500208.SGD","LU2347655156.SGD","BK4534","BUZZ","BK4588","BK4504","LU1430594728.SGD","LU2468319806.SGD","BK4082","BK4533","LU1935042991.SGD","SG9999002224.SGD","BK4139","LU1244550494.USD","LU1585245621.USD","LU2133065610.SGD","BK4592","JNJ","LU1023059063.AUD","LU1221951129.SGD","IE00B7SZLL34.SGD","LU0640476718.USD","LU1032955483.USD","LU1221951046.USD","LU1057294990.SGD","LU2602419157.SGD","LU0889566641.SGD","LU0234572021.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ambrx.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0.0021},{"period":"1year","weight":1.1407},{"period":"ytd","weight":0.9663}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ambrx Biopharma, Inc.是一家根据特拉华州法律成立的公司。该公司是一家临床阶段的生物制剂公司,专注于发现和开发一类新的工程精密生物制剂(EPBs),利用其专有的扩展遗传密码技术平台,使他们能够以特定地点的方式将合成氨基酸(SAA)整合到活细胞内的蛋白质中。它们的候选产品旨在克服传统结合方法的固有局限性,这些方法使用天然氨基酸进行非位点特异性结合,为治疗多个治疗领域的患者提供潜在的安全性和有效性益处。","exchange":"NASDAQ","name":"Ambrx Biopharma Inc","nameEN":"Ambrx Biopharma Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ambrx Biopharma Inc(AMAM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ambrx Biopharma Inc(AMAM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ambrx Biopharma Inc,AMAM,Ambrx Biopharma Inc股票,Ambrx Biopharma Inc股票老虎,Ambrx Biopharma Inc股票老虎国际,Ambrx Biopharma Inc行情,Ambrx Biopharma Inc股票行情,Ambrx Biopharma Inc股价,Ambrx Biopharma Inc股市,Ambrx Biopharma Inc股票价格,Ambrx Biopharma Inc股票交易,Ambrx Biopharma Inc股票购买,Ambrx Biopharma Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ambrx Biopharma Inc(AMAM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ambrx Biopharma Inc(AMAM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}